These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1113 related articles for article (PubMed ID: 24997276)
1. Antibiotic-free nanotherapeutics: ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors. Nafee N; Husari A; Maurer CK; Lu C; de Rossi C; Steinbach A; Hartmann RW; Lehr CM; Schneider M J Control Release; 2014 Oct; 192():131-40. PubMed ID: 24997276 [TBL] [Abstract][Full Text] [Related]
2. Enzyme-Linked Lipid Nanocarriers for Coping Pseudomonal Pulmonary Infection. Would Nanocarriers Complement Biofilm Disruption or Pave Its Road? Nafee N; Gaber DM; Abouelfetouh A; Alseqely M; Empting M; Schneider M Int J Nanomedicine; 2024; 19():3861-3890. PubMed ID: 38708178 [TBL] [Abstract][Full Text] [Related]
3. Pseudomonas aeruginosa pyocyanin production reduced by quorum-sensing inhibiting nanocarriers. Lu HD; Pearson E; Ristroph KD; Duncan GA; Ensign LM; Suk JS; Hanes J; Prud'homme RK Int J Pharm; 2018 Jun; 544(1):75-82. PubMed ID: 29608955 [TBL] [Abstract][Full Text] [Related]
4. Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in a mouse peritoneal implant infection model. Luo J; Dong B; Wang K; Cai S; Liu T; Cheng X; Lei D; Chen Y; Li Y; Kong J; Chen Y PLoS One; 2017; 12(4):e0176883. PubMed ID: 28453568 [TBL] [Abstract][Full Text] [Related]
5. Sodium colistimethate loaded lipid nanocarriers for the treatment of Pseudomonas aeruginosa infections associated with cystic fibrosis. Pastor M; Moreno-Sastre M; Esquisabel A; Sans E; Viñas M; Bachiller D; Asensio VJ; Pozo AD; Gainza E; Pedraz JL Int J Pharm; 2014 Dec; 477(1-2):485-94. PubMed ID: 25445528 [TBL] [Abstract][Full Text] [Related]
6. Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor. Furiga A; Lajoie B; El Hage S; Baziard G; Roques C Antimicrob Agents Chemother; 2015 Dec; 60(3):1676-86. PubMed ID: 26711774 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of quorum-sensing-dependent virulence factors and biofilm formation of clinical and environmental Pseudomonas aeruginosa strains by ZnO nanoparticles. García-Lara B; Saucedo-Mora MÁ; Roldán-Sánchez JA; Pérez-Eretza B; Ramasamy M; Lee J; Coria-Jimenez R; Tapia M; Varela-Guerrero V; García-Contreras R Lett Appl Microbiol; 2015 Sep; 61(3):299-305. PubMed ID: 26084709 [TBL] [Abstract][Full Text] [Related]
8. Targeting quorum sensing in Pseudomonas aeruginosa biofilms: current and emerging inhibitors. Jakobsen TH; Bjarnsholt T; Jensen PØ; Givskov M; Høiby N Future Microbiol; 2013 Jul; 8(7):901-21. PubMed ID: 23841636 [TBL] [Abstract][Full Text] [Related]
9. Antipathogenic potential of Rhizophora spp. against the quorum sensing mediated virulence factors production in drug resistant Pseudomonas aeruginosa. Annapoorani A; Kalpana B; Musthafa KS; Pandian SK; Ravi AV Phytomedicine; 2013 Aug; 20(11):956-63. PubMed ID: 23746758 [TBL] [Abstract][Full Text] [Related]
10. Chen T; Sheng J; Fu Y; Li M; Wang J; Jia AQ J Proteome Res; 2017 Feb; 16(2):824-830. PubMed ID: 28094526 [TBL] [Abstract][Full Text] [Related]
12. Hybrids of acylated homoserine lactone and nitric oxide donors as inhibitors of quorum sensing and virulence factors in Pseudomonas aeruginosa. Kutty SK; Barraud N; Ho KK; Iskander GM; Griffith R; Rice SA; Bhadbhade M; Willcox MD; Black DS; Kumar N Org Biomol Chem; 2015 Oct; 13(38):9850-61. PubMed ID: 26282835 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of the production of the Pseudomonas aeruginosa virulence factor pyocyanin in wild-type cells by quorum sensing autoinducer-mimics. Morkunas B; Galloway WR; Wright M; Ibbeson BM; Hodgkinson JT; O'Connell KM; Bartolucci N; Della Valle M; Welch M; Spring DR Org Biomol Chem; 2012 Nov; 10(42):8452-64. PubMed ID: 23014532 [TBL] [Abstract][Full Text] [Related]
14. Crataeva nurvala nanoparticles inhibit virulence factors and biofilm formation in clinical isolates of Pseudomonas aeruginosa. Ali SG; Ansari MA; Khan HM; Jalal M; Mahdi AA; Cameotra SS J Basic Microbiol; 2017 Mar; 57(3):193-203. PubMed ID: 27874198 [TBL] [Abstract][Full Text] [Related]
16. Toward Repositioning Niclosamide for Antivirulence Therapy of Pseudomonas aeruginosa Lung Infections: Development of Inhalable Formulations through Nanosuspension Technology. Costabile G; d'Angelo I; Rampioni G; Bondì R; Pompili B; Ascenzioni F; Mitidieri E; d'Emmanuele di Villa Bianca R; Sorrentino R; Miro A; Quaglia F; Imperi F; Leoni L; Ungaro F Mol Pharm; 2015 Aug; 12(8):2604-17. PubMed ID: 25974285 [TBL] [Abstract][Full Text] [Related]
17. Nebulized solid lipid nanoparticles for the potential treatment of pulmonary hypertension via targeted delivery of phosphodiesterase-5-inhibitor. Makled S; Nafee N; Boraie N Int J Pharm; 2017 Jan; 517(1-2):312-321. PubMed ID: 27979766 [TBL] [Abstract][Full Text] [Related]
18. Amphypterygium adstringens anacardic acid mixture inhibits quorum sensing-controlled virulence factors of Chromobacterium violaceum and Pseudomonas aeruginosa. Castillo-Juárez I; García-Contreras R; Velázquez-Guadarrama N; Soto-Hernández M; Martínez-Vázquez M Arch Med Res; 2013 Oct; 44(7):488-94. PubMed ID: 24126126 [TBL] [Abstract][Full Text] [Related]
19. Bismuth-thiol incorporation enhances biological activities of liposomal tobramycin against bacterial biofilm and quorum sensing molecules production by Pseudomonas aeruginosa. Halwani M; Hebert S; Suntres ZE; Lafrenie RM; Azghani AO; Omri A Int J Pharm; 2009 May; 373(1-2):141-6. PubMed ID: 19429299 [TBL] [Abstract][Full Text] [Related]
20. Chlorogenic acid attenuates virulence factors and pathogenicity of Pseudomonas aeruginosa by regulating quorum sensing. Wang H; Chu W; Ye C; Gaeta B; Tao H; Wang M; Qiu Z Appl Microbiol Biotechnol; 2019 Jan; 103(2):903-915. PubMed ID: 30421108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]